HIGHLIGHTS
- who: Xue Wang from the The University of Tokyo, Japan have published the research: Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia, in the Journal: (JOURNAL)
- how: This result is consistent with the experimental CETSA data.
SUMMARY
Considering TLR4 is a XAMPs receptor for surveiling foreign substances in CNS, it would be interesting to explore whether CBDV acts as a XAMP and can be sensed by MD2, an accessory protein of TLR4 responsible for the recognition of ligand. The P-value was set at ## P . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.